EcoDrugPlus

Sodium/potassium-Transporting Atpase Subunit Alpha-2

Ensembl ID : ENSCMIG00000013455
Gene Symbol: LOC103191236
3 Cross references
209 Possible Orthologues:

Solute Carrier Family 10 Member 2

Ensembl ID : ENSCMIG00000005941
Gene Symbol: SLC10A2
4 Cross references
211 Possible Orthologues:

Solute Carrier Family 18 Member A2

Ensembl ID : ENSCMIG00000018605
Gene Symbol: SLC18A2
3 Cross references
225 Possible Orthologues:

Solute Carrier Family 22 Member 20, Pseudogene

Ensembl ID : ENSCMIG00000007893
Gene Symbol: SLC22A20P
4 Cross references
362 Possible Orthologues:

Solute Carrier Family 29 Member 1 (Augustine Blood Group)

Ensembl ID : ENSCMIG00000016979
Gene Symbol: SLC29A1
4 Cross references
280 Possible Orthologues:

Solute Carrier Family 5 Member 1

Ensembl ID : ENSCMIG00000004517
Gene Symbol: SLC5A1
3 Cross references
250 Possible Orthologues:

Solute Carrier Family 6 Member 1

Ensembl ID : ENSCMIG00000004964
Gene Symbol: SLC6A1
3 Cross references
281 Possible Orthologues:

Solute Carrier Family 6 Member 2

Ensembl ID : ENSCMIG00000017951
Gene Symbol: SLC6A2
2 Cross references
204 Possible Orthologues:

Solute Carrier Family 6 Member 3

Ensembl ID : ENSCMIG00000016555
Gene Symbol: SLC6A3
4 Cross references
167 Possible Orthologues:

Solute Carrier Family 6 Member 4

Ensembl ID : ENSCMIG00000013329
Gene Symbol: SLC6A4
4 Cross references
205 Possible Orthologues:

Solute Carrier Family 6 Member 9

Ensembl ID : ENSCMIG00000010383
Gene Symbol: SLC6A9
4 Cross references
207 Possible Orthologues:

Solute Carrier Family 9 Member A3

Ensembl ID : ENSCMIG00000019798
Gene Symbol: SLC9A3
4 Cross references
238 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).